Literature DB >> 22846854

Introduction: hepatocellular carcinoma.

Brian I Carr.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22846854     DOI： 10.1053/j.seminoncol.2012.06.001

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway.

Authors:  Dafeng Xu; Yu Wang; Jincai Wu; Zhensheng Zhang; Jiacheng Chen; Mingwei Xie; Rong Tang; Cheng Chen; Liang Chen; Shixun Lin; Xiangxiang Luo; Jinfang Zheng
Journal:  Cell Death Dis       Date:  2021-02-08       Impact factor: 8.469

2.  Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.

Authors:  Jingyang Zhou; Jinhui Che; Lu Xu; Weizhong Yang; Yunmei Li; Wuyuan Zhou; Shubing Zou
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

3.  Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis.

Authors:  Dong Liu; Jian-Ming Fang; Xian-Qi Chen
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.